1. Home
  2. Southern Africa
  3. Mozambique
  • News

No HIV/AIDS drug roll-out in February

Mozambique's Health Ministry has dismissed reports that the government is about to provide antiretroviral drugs to HIV-positive people in the central city of Beira. The Mozambican news agency AIM reported on Thursday an announcement by Sofala provincial health director, Alberto Baptista, that Beira Central Hospital would be ready to dispense antiretroviral drugs in February. "No funding has been allocated to dispense and monitor HIV/AIDS treatment for the city of Beira," head of the epidemiological department of the Ministry of Health, Dr. Rosa Marlene Lanjate, told the UN news service Plusnews. "The clinic at Beira Central Hospital was launched in September 2002 only for the monitoring and evaluation of PWAs, and not to dispense HIV/AIDS drugs," Lanjate said. The government is still negotiating a US $55 million World Bank grant for a number of HIV/AIDS programmes, including the provision of treatment, Lanjate added.

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join